258 related articles for article (PubMed ID: 19447499)
21. Copper(II), nickel(II) and zinc(II) complexes of N-acetyl-His-Pro-His-His-NH2: equilibria, solution structure and enzyme mimicking.
Jakab NI; Jancsó A; Gajda T; Gyurcsik B; Rockenbauer A
J Inorg Biochem; 2008 Jul; 102(7):1438-48. PubMed ID: 18289685
[TBL] [Abstract][Full Text] [Related]
22. A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity.
Tjin Tham Sjin RM; Satchi-Fainaro R; Birsner AE; Ramanujam VM; Folkman J; Javaherian K
Cancer Res; 2005 May; 65(9):3656-63. PubMed ID: 15867360
[TBL] [Abstract][Full Text] [Related]
23. The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor.
Travaglia A; Arena G; Fattorusso R; Isernia C; La Mendola D; Malgieri G; Nicoletti VG; Rizzarelli E
Chemistry; 2011 Mar; 17(13):3726-38. PubMed ID: 21394800
[TBL] [Abstract][Full Text] [Related]
24. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
Faller P; Hureau C
Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
[TBL] [Abstract][Full Text] [Related]
25. Interaction of Cu(II) and Ni(II) with the 63-93 fragment of histone H2B.
Zavitsanos K; Nunes AM; Malandrinos G; Kállay C; Sóvágó I; Magafa V; Cordopatis P; Hadjiliadis N
Dalton Trans; 2008 Nov; (44):6179-87. PubMed ID: 18985251
[TBL] [Abstract][Full Text] [Related]
26. Copper(II) interaction with unstructured prion domain outside the octarepeat region: speciation, stability, and binding details of copper(II) complexes with PrP106-126 peptides.
Di Natale G; Grasso G; Impellizzeri G; La Mendola D; Micera G; Mihala N; Nagy Z; Osz K; Pappalardo G; Rigó V; Rizzarelli E; Sanna D; Sóvágó I
Inorg Chem; 2005 Oct; 44(20):7214-25. PubMed ID: 16180886
[TBL] [Abstract][Full Text] [Related]
27. Probing the copper(II) binding features of angiogenin. Similarities and differences between a N-terminus peptide fragment and the recombinant human protein.
La Mendola D; Farkas D; Bellia F; Magrì A; Travaglia A; Hansson Ö; Rizzarelli E
Inorg Chem; 2012 Jan; 51(1):128-41. PubMed ID: 22148849
[TBL] [Abstract][Full Text] [Related]
28. Probing the Cu(2+) and Zn(2+) binding affinity of histidine-rich glycoprotein.
Jancsó A; Kolozsi A; Gyurcsik B; Nagy NV; Gajda T
J Inorg Biochem; 2009 Dec; 103(12):1634-43. PubMed ID: 19786305
[TBL] [Abstract][Full Text] [Related]
29. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract][Full Text] [Related]
30. Zinc-binding of endostatin is essential for its antiangiogenic activity.
Boehm T; O'reilly MS; Keough K; Shiloach J; Shapiro R; Folkman J
Biochem Biophys Res Commun; 1998 Nov; 252(1):190-4. PubMed ID: 9813168
[TBL] [Abstract][Full Text] [Related]
31. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.
Zhao H; Jutila A; Nurminen T; Wickström SA; Keski-Oja J; Kinnunen PK
Biochemistry; 2005 Mar; 44(8):2857-63. PubMed ID: 15723529
[TBL] [Abstract][Full Text] [Related]
32. Copper(II) binding to two novel histidine-containing model hexapeptides: evidence for a metal ion driven turn conformation.
Di Natale G; Damante CA; Nagy Z; Osz K; Pappalardo G; Rizzarelli E; Sóvágó I
J Inorg Biochem; 2008 Nov; 102(11):2012-9. PubMed ID: 18796344
[TBL] [Abstract][Full Text] [Related]
33. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
[TBL] [Abstract][Full Text] [Related]
34. Copper(II) binding to Cap43 protein fragments.
Zoroddu MA; Kowalik-Jankowska T; Medici S; Peana M; Kozlowski H
Dalton Trans; 2008 Nov; (44):6127-34. PubMed ID: 18985244
[TBL] [Abstract][Full Text] [Related]
35. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
[TBL] [Abstract][Full Text] [Related]
36. Unraveling the mysteries of endostatin.
Fu Y; Tang H; Huang Y; Song N; Luo Y
IUBMB Life; 2009 Jun; 61(6):613-26. PubMed ID: 19472178
[TBL] [Abstract][Full Text] [Related]
37. A new, model-free calculation method to determine the coordination modes and distribution of copper(II) among the metal binding sites of multihistidine peptides using circular dichroism spectroscopy.
Osz K
J Inorg Biochem; 2008 Dec; 102(12):2184-95. PubMed ID: 18973951
[TBL] [Abstract][Full Text] [Related]
38. Engineering of a disulfide loop instead of a Zn binding loop restores the anti-proliferative, anti-angiogenic and anti-tumor activities of the N-terminal fragment of endostatin: Mechanistic and therapeutic insights.
Chamani R; Asghari SM; Alizadeh AM; Eskandari S; Mansouri K; Khodarahmi R; Taghdir M; Heidari Z; Gorji A; Aliakbar A; Ranjbar B; Khajeh K
Vascul Pharmacol; 2015 Sep; 72():73-82. PubMed ID: 26187352
[TBL] [Abstract][Full Text] [Related]
39. A comparative study on the possible zinc binding sites of the human ZnT3 zinc transporter protein.
Árus D; Dancs Á; Nagy NV; Gajda T
Dalton Trans; 2013 Sep; 42(33):12031-40. PubMed ID: 23839275
[TBL] [Abstract][Full Text] [Related]
40. Research advances of endostatin and its short internal fragments.
Xu HL; Tan HN; Wang FS; Tang W
Curr Protein Pept Sci; 2008 Jun; 9(3):275-83. PubMed ID: 18537682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
